Investegate |Idorsia Pharmaceuticals Ltd Announcements | Idorsia Pharmaceuticals Ltd: Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension

Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension

Related Keywords

Australia ,United States ,Allschwil ,Switzerland General ,Switzerland ,Dublin ,Ireland ,America ,American ,Swiss ,Andrewc Weiss ,Clozelm Aprocitentan ,Jean Paul Clozel ,Markus Schlaich ,Arterioscler Thromb Vasc ,J Physiol Pharmacol ,Idorsia Ltd ,American Heart Association ,Head Of Investor Relations Corporate Communications ,Janssen Biotech Inc ,Drug Administration ,Swiss Exchange ,Janssen Pharmaceutical Companies Of Johnson ,Idorsia Pharmaceuticals Ltd ,New Drug Application ,Late Breaking Science ,Scientific Sessions ,Paul Clozel ,Chief Executive Officer ,Janssen Pharmaceutical Companies ,Janssen Biotech ,African American ,North America ,Pressure Lowering Treatment Trialist ,Heart Journal ,Scientific Statement From ,American Heart ,Rev Pharmacol ,Factor Collaboration ,Thromb Vasc Biol ,Clin Hypertension ,Vice President ,Investor Relations ,Pharmaceuticals Ltd ,Investegate Announcements ,Investegate Company Announcements ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,